Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
7
×
life sciences
national blog main
7
×
national top stories
raleigh-durham blog main
7
×
raleigh-durham top stories
san francisco blog main
san francisco top stories
biotech
detroit blog main
detroit top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
clinical trials
fda
ipo
pfizer
boehringer ingelheim
cancer immunotherapy
crispr
deals
eli lilly
medical devices
merck
moderna
What
life
7
×
science
bio
companies
roundup
ipo
week
biotechs
firms
millions
moves
new
public
sciences
therapeutics
admits
ago
arena’s
bails
becker
big
billions
black
blood
bounty
brand
bridgebio
broader
cancer
capital
car
cig
classes
club
combinator
comeback
company
continue
continued
corner
Language
unset
Current search:
life
×
" national blog main "
×
" raleigh-durham blog main "
×
cancer
×
@xconomy.com
4 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M